Background The study investigated the early healing process following the treatment of single Miller class I and II recessions with a 3D xenogeneic collagen matrix (CMX) or connective tissue graft (CTG). Methods This pilot investigation was designed as a singlecenter randomized controlled parallel trial. A total of eight subjects (four per group) were treated with either CMX or CTG in the anterior maxilla. Vascular flow changes were assessed by laser Doppler flowmetry (LDF) before and after surgery and at days 1, 2, 3, 7, 14, and 30 while clinical evaluations took place at baseline and at days 60 and 180. Pain intensity perception was evaluated by the short-form McGill pain questionnaire (SF-MPQ), at days 1 and 14. Results The vascular flow fluctuated similarly in both groups pre-and post-operatively, but the CTG exhibited a more homogeneous pattern as opposed to CMX that showed a second phase of increased blood flow at 14 days. Clinically, the CTG led to greater change in mean root coverage and keratinized tissue gain but CMX was associated with lower early pain intensity scores.
Introduction
The recession of the gingival margin is a common clinical finding in the dentition of adults [1, 2] and may have an impact on the aesthetics, function, and comfort of the patient [3] . Among the different modalities for root coverage, bilaminar flap techniques offer the greatest long-term predictability in terms of percentage of root coverage and complete root coverage and these are primarily used especially when the gingival biotype is thin [4] .
Although the autogenous connective tissue graft (CTG) is still considered the Bgold standard^for use in bilaminar techniques, alternative soft-tissue grafting materials have been introduced yielding favorable results [4] . A novel material for soft-tissue regeneration fabricated as a double-layer matrix, composed of pure porcine collagen (3D xenogeneic collagen matrix-CMX) obtained by standardized, controlled manufacturing processes, has been shown to be effective in attaining a band of keratinized tissue with significantly less patient morbidity [5, 6] . The application of this material has Summary findings The vascular flow alterations during the early healing of connective tissue graft and collagen matrix after root coverage procedures followed a similar pattern overall, but a trend for better clinical performance and greater initial morbidity was noted for the connective tissue graft.
been also expanded to root coverage procedures with positive outcomes [7] [8] [9] [10] . Patient-and therapist-related factors such as the availability of donor tissue, post-operative morbidity, and surgical time are the main determinants for the application of allogeneic or xenogeneic tissue [4] .
Successful healing following mucogingival surgery is influenced by the wound revascularization rate, as well as by the preservation and the reconstruction of the microvasculature of the gingival tissues [5, 6] . Laser Doppler flowmetry (LDF) is a method used for monitoring the blood perfusion in skin transplants and flaps where early signs of impaired circulation can be detected [7] . Thus, it can promote the prevention of transplant loss by providing reliable and readily accessible information with regards to the state of the flap blood flow [8] . LDF has been shown to be applicable in the field of periodontics describing the blood flow pattern of access periodontal flaps [9] .
Bilaminar techniques in mucogingival surgery offer a good investigational model to evaluate the healing process through the changes in the microvascular flow, as assessed by LDF. To date, there has been no reported study applying the above methodology for root coverage procedures; thus, a pilot investigation was designed with the following objectives:
& To evaluate the early healing process following the treatment of single gingival recessions with either CMX or CTG as assessed by changes in blood flow at set time points during early healing & To record changes in clinical gingival recession measurements and keratinized gingiva width during early healing as well as the patients' perception of pain intensity during the same period.
The null hypothesis was that the early healing events from vascular, clinical, and patient perspectives does not differ significantly when a CMX or a CTG is used for the treatment of single-recession defects.
Materials and methods
Candidate participants were referred to the Eastman Clinical Investigation Centre (ECIC) of the Unit of Periodontology, UCL Eastman Dental Institute, for the management of their gingival recession. Patients were enrolled in the study if they fulfilled all the following inclusion criteria: (i) 18 years or older, (ii) good general health, (iii) single Miller [10] class I/II buccal recession defects ≥ 4 mm (on maxillary teeth from nos. 15 to 25), (iv) full-mouth plaque score (FMPS) and fullmouth gingival score (FMBS) of ≤ 20%.
All subjects signed the informed consent form as approved by the UCL/UCLH/Royal Free Joint Research Office, and the study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2013.
Clinical procedures

Pre-surgical phase
Patients were examined at screening and baseline appointments to determine and confirm eligibility for inclusion in the study. At the baseline visit, a trained and calibrated examiner (N.T.) collected the following clinical measures:
(i) percentage of total surfaces (six aspects per tooth) that revealed the presence of plaque (FMPS); (ii) percentage of total surfaces (six aspects per tooth) that presented bleeding on probing from the base of the pocket (FMBS); (iii) pocket-probing depth (PPD), gingival recession (REC), and clinical attachment level (CAL) in six aspects per tooth were recorded to the nearest millimeter with a standard manual periodontal probe (UNC15, HuFriedy, Chicago, IL, USA); (iv) width of keratinized tissue (WKT) on the mid-facial surface of the treated and its adjacent teeth as well as gingival biotype thickness (GT) on the treated tooth as previously described [11] . The periodontal probe was inserted in the middle region of the facial sulcus, and if its outline was visible through the tissues, the biotype was classified as thin; otherwise, it was categorized as thick; (v) diagnosis of recession according to the Miller's classification [10] of the tooth to be treated
Following baseline assessment, all subjects went through a dental hygiene session with the provision of supragingival debridement and oral hygiene instructions to ensure that the participants maintained optimal levels of plaque control and avoid local trauma prior to the surgery. An alginate impression was also taken for the fabrication of a customized hard acrylic stent which was used for the standardized measurements by the LDF instrument, as previously reported [9] .
Randomization and surgical phase
Each patient was randomly assigned by a computer-generated table to receive one of the two treatments (CMX or CTG). The study coordinator prepared a sealed envelope containing the allocated treatment, which was opened during the surgery once the recipient bed had been prepared. The surgical procedure was performed as follows by one experienced therapist (U.D.) (Fig. 3 ):
The exposed root surface was planed using hand instruments. A trapezoid flap was created with two vertical incisions placed mesially and distally to the area of gingival recession. The rounded incisions terminated at the level of the cementoenamel junction (CEJ) and were connected by an intrasulcular incision, leaving the interproximal papillae intact. A full thickness flap was raised apically to the mucogingival line. A periosteal-releasing incision was made to mobilize the flap and enable tension-free coronal advancement. The papillae mesial and distal to the recession defect were de-epithelialized. At that stage, the randomization envelope was opened to disclose the treatment modality. The CMX was prepared according to the manufacturer's instructions and was trimmed to completely cover the exposed root surface from the CEJ, extending 1.0 mm laterally and 2.0 or 3.0 mm apically beyond the osseous margins of the dehiscence. The CTG was obtained from the palate and was trimmed to cover the exposed root surface, extending 2.0 to 4.0 mm peripherally.
The graft was fixed using a sling technique with 5.0 resorbable sutures (Vicryl, Ethicon, Germany). The flaps were coronally advanced aiming at complete coverage and were sutured using again a sling suture technique with the same type of material. The vertical incisions and the papillary areas were closed with single interrupted sutures. When a CTG was used, the palatal donor side was sutured with single interrupted sutures to obtain primary closure.
Post-operative care included the intake of 1 g of paracetamol immediately after surgery and thereafter the use of 500 mg of paracetamol or 400 mg ibuprofen every 6-8 h as needed for the management of discomfort. Moreover, rinsing with 0.2% chlorhexidine gluconate solution was prescribed twice daily for 1 min for 2 weeks. All sutures but the sling of the graft was removed after 14 days. The latter was removed at 30 days. Patients were instructed in appropriate post-operative home care and were motivated in the control of their oral hygiene at each visit.
LDF assessments
The application of LDF in periodontal surgery has been previously described [9, 12] . A commercially available laser Doppler flowmeter (5010 Periflux, Perimed, Jarfalla, Sweden) with wavelength 780 nm equipped with a standard probe (PF416 with outside diameter 1.0 mm and fiber separation 0.25 mm) was used for all measurements. The flowmeter time constant was 0.2 s, with an upper bandwidth at 20 kHz and lower bandwidth at 20 Hz. The instruments and fiberoptic probes were calibrated by means of the Perimed PF 1000 motility standard according to the manufacturers' specifications before each measurement. The signals were recorded in arbitrary perfusion units and monitored using the Perisoft software (Version 2.10, Perimed AB).
The LDF study measurements were performed with the use of individual acrylic stents (4-6 mm thick) extending to the gingival and alveolar mucosal surfaces of the operated tooth [9] . A wax spacer (0.5 mm) was applied over the gingival area of the cast models in order to prevent the stent from applying pressure on the gingival tissues. This also ensured that the LDF probe was always at a distance of approximately 0.5 mm from the tissues. The recordings of the LDF probe were made through holes drilled on the acrylic stent in standardized buccal locations for each tooth, one in the middle of the mid-facial aspect of the gingivae and one at the level of the mucogingival junction. In cases where the width of keratinized tissue was less than 2 mm, a second hole was made 1 mm apical to the mucogingival junction. The thickness of the acrylic stent around the holes was 5 mm, similar to the length of the LDF probe.
All LDF measurements were performed by the same previously calibrated examiner (N.T.). The subjects were comfortably seated and relaxed in a semi-reclined position in the dental chair in a room with controlled temperature. The tip of the fiber-optic probe was inserted into the holes of the acrylic stent and thus held motionless relative to the tissues during continuous measurements. Two 60-s measurements were taken in each hole of the acrylic stent per treated tooth. The assessments were performed at the following time points: on the day of the surgery before the injection of the local anesthesia, 5 min following local anesthesia induction, immediately following completion of the surgical procedure, and at postoperative days 1, 2, 3, 7, 14, and 30.
Clinical and questionnaire assessments
Clinical assessments were performed at 2 and 6 months postsurgery. At the 6-month visit, clinical measurements similar to the baseline were collected while at 2 months, only partialmouth recordings involving the treated and its adjacent teeth were documented. At the end of both study visits, a dental hygiene session with supragingival debridement was completed.
In addition to the above, at days 1 and 14, patients were asked to complete the short form of the McGill pain questionnaire (SF-MPQ) [13] .
Reproducibility of outcome measures
The reproducibility of the LDF measurements was tested before the initiation of the study. Five periodontally healthy volunteers were recruited, and stents similar to the ones prepared for the study measurements were used. The same recording script that was prepared for the actual study measurements was formatted for the calibration session, and a 1-min LDF recording was performed in duplicate for each of the two selected measurement sites. Two separate rounds of measurements, at least 30 min apart, were completed for each subject. The concordance correlation coefficient among measurements for the most coronal site was 0.920 (the Pearson correlation coefficient was 0.926) and for the apical site was 0.812 (the Pearson correlation coefficient was 0.849).
Statistical analysis
This study was designed as a pilot; hence, due to the limited sample size, only descriptive statistics were performed using the SPSS software (SPSS 11.0, Chicago, IL). The clinical variables are presented as means with their respective standard deviations. As relates to the LDF recordings, all periods capturing artifact data by the relative motion of the probe were excluded and an average of the 1-min period of each individual recording was calculated by the Perisoft computer program (Version 2.10, Perimed, Stockholm, Sweden) [9, 12] . Changes of blood flux values in the two selected locations were expressed as the difference (ΔPU) between the perfusion unit (PU) value at a specific site at a specific observation time point (PU t ) and the individual baseline value of the same site (PU 0 ): ΔPU = PU t − PU 0 .
Results
Eight subjects (four per group) were recruited and completed this pilot investigation (Fig. 1) . The intraoral healing progressed uneventfully in all cases. One patient in the control group was hospitalized because of a lower limb fracture but attended all study visits, and one patient in the test group undertook emergency gynecological surgery and did not attend the post-operative visits at days 2 and 3 ( Fig. 2) . Patients' background characteristics are presented in Table 1 . All study participants were non-smoker Caucasians, and each contributed one maxillary canine for treatment. The mean ages of the control group and test group were 37.75 ± 18.17 and 38.75 ± 11.70 years, respectively.
Clinical measures
The full-mouth and tooth-specific clinical measures are presented in Table 2 . Over the study period, the mean recession depth of the CTG group was reduced from 4.5 ± 0.58 to 1.0 ± 0.82 mm and that of the CMX group from 4.0 to 2.0 ± 0.82 mm. Both groups exhibited an increase in the keratinized tissue width, but this was more evident for the control (from 3.0 ± 2.45 to 4.0 ± 1.83 mm) compared to the test group (from 1.5 ± 0.58 to 1.75 ± 0.50 mm). One case in each group converted to a thick gingival biotype at the end of the study period (Fig. 3) .
LDF measures
The changes in the vascular flow during the LDF observation period for each of the stent sites per group are illustrated in Figs. 4 and 5. In the coronal site, the CMX group showed a fluctuant pattern of blood flow, with two peaks, at days 1 and 14, and a drop in the interim period. The CTG group showed a more homogeneous curve and overall lower mean values with the exception of the perioperative period and day 3.
In the apical area of the stent, the test group had consistently higher mean values of blood flow and two distinct peaks at days 2 and 14. On the contrary, the control group demonstrated one main peak at the third post-operative day. Table 3 summarizes the questionnaire data per group at the two selected time points. The overall scores reduced in both groups from the 1st to the 14th post-operative day with the CMX/Test group 6 months (n=4) Fig. 1 Flowchart of patients screened, eligible, and finally included in the study. There were no losses to follow-up from the enrolled (n = 8) patients control group scoring higher at day 1, indicating greater morbidity. Interestingly, the test group exhibited higher scores at day 14.
Questionnaire measures
Discussion
Soft-tissue replacement grafts offer certain advantages such as increased surgical efficiency and reduced patient morbidity. CMX was originally introduced as an alternative to free gingival graft to increase the width of keratinized mucosa [14] , and its application has been expanded to cover single-and multiple-recession defects with bilaminar techniques [15] [16] [17] [18] [19] [20] .
The presented proof-of-concept investigation was primarily designed to observe the vascular healing and blood flow changes with the use of LDF, following two distinct surgical modalities after the management of single Miller class I/II recessions in the anterior maxilla. Secondarily, clinical and patient-reported outcome measures were also evaluated.
For both groups, the vascular changes noted at the day of the surgery followed the same trends that had been previously documented after the administration of local anesthesia with vasoconstriction [9, 12, 21] . A significant drop in the vascular flow was observed initially in both groups while at the end of the surgery, an increase was expected and this was more obviously closer to the gingival margin compared to the apical portion of the flap. The response could be probably attributed to the ongoing effect of the infiltrated vasoconstrictor close to the mucogingival junction, which moderated any significant changes.
In the CMX group, the blood flow continued to increase up to day 1 in the coronal point and to day 2 in the apical point of the stent, exhibiting generally higher mean values to the control group. The organization of the clot takes place mainly during the first 2-3 days after the elevation of a fullthickness mucoperiosteal flap [22] , but the pronounced hyperemic response of the test group may be possibly explained by the fact that the CMX material provides a Bmatrix-like^layer for blood absorption as opposed to the structurally compact autogenous graft. By the end of the first week, the blood flow was gradually reduced and a second peak was noted at day 14 for the CMX recipients. This was an interesting finding because it may indicate a reactivation in the vascular flow, possibly resulted from the degradation process of the collagen matrix.
There have been previous studies in animal models that followed the vascularization process of subepithelial connective tissue grafts and implanted collagenous matrices comparable to the one used for this study. Guiha and coworkers [23] noted that at the end of the second post-surgical week, the well-adapted connective tissue graft was practically vascularized in the dog, while at the 28th day, the different Fig. 2 Timeline of the study visits (BL, baseline; OH, oral hygiene visit; Sx, surgical treatment visit; D1, day 1; D2, day 2; D3, day 3; D7, day 7; D14, day 14; 1M, 1 month; 2M, 2 months; 6M, 6 months) and the corresponding clinical procedures or assessments performed in each of them Tooth treated (N) 2 × #13/2 × #23 3 × #13 / 1× #23 microvascular plexuses had been established. This is in line with our findings because no major changes occurred in the control group between the 2nd and 4th weeks. On the other hand, the degradation of the matrix appears to be related to the vascularization process. In a murine subcutaneous model, non-cross-linked, bilayered porcine collagen (types I and III) membranes demonstrated a homogeneous transmembranous pattern of angiogenesis as early as 2 weeks post-implantation [24] . Interestingly, when the CMX scaffold was implanted in subcutaneous pouches in mice, breakdown signs were not evident before 30 days elapsed, even though cellular penetration was noted as early as 3 days after the surgery. After 10-15 days, the greatest reduction in thickness of the non-porous layer occurred and this was associated with further cellular ingrowth. Little increase in the vascularization was overall observed, though, and this was confined to the spongy layer of the matrix [25] . When the matrix was implanted in oral submucosal pouches in pigs, its resorption was completed by day 30 while the first signs of degradation were observed after 15 days and these were associated with an inflammatory infiltrate at the porous layer of the matrix [26] . Even though the above models cannot provide robust evidence regarding the post-operative revascularization process of the implantation site, it can be speculated that the following process may take place: during the 2nd-week peak, increased blood flow is triggered as a result of macrophages from the bloodstream eliciting an inflammatory reaction that drives the biodegradation of the matrix and promotes the incorporation of the surrounding tissues.
The early vascular responses from our study indicated that the blood flow returned close to the baseline values after 2 weeks and that the normalization took place quicker at the CTG group. The above observation was noted by another recent clinical study where a different laser imaging methodology was applied [27] . The authors treated adjacent recessions with CTG or CMX using a tunneling approach, and although they detected a different pattern of vascular changes between men and women, they acknowledged that the CTG group rebounded faster to the baseline values and that the CMX-treated patients exhibited a greater hyperemic response overall. It has been reported that microsurgical approaches enhance the revascularization of the wound in recession coverage surgeries, which may translate to better clinical outcomes [28, 29] . The CMX, as opposed to the CTG, does not carry an internal vascular structure; therefore, in order for capillary ingrowth and vascular plexus development to take place, remodeling of the scaffold is necessary. This possibly explains the prolonged revascularization phase of the CMX recipients, but this behavior did not hamper its incorporation and the healing of the sites. On the other hand, whether the above has an impact on the post-surgical clinical outcomes remains to be determined by future studies.
As relates to the clinical measures and within the limits of this pilot study, the results conform to the available evidence from previously published systematic reviews and meta-analyses, which indicates a superiority of the autogenous tissue when it comes to mean (%) recession root coverage and mean recession reduction [30] [31] [32] In relation to the change in the keratinized tissue width, our study demonstrated a higher mean increase at the control group (1.25 vs. 0.25 mm) which was slightly different from previous studies [18, 15] . In both studies, however, although statistically significant differences were identified, these did not necessarily signify a clinically substantial difference between treatment groups. The inconclusive results have been also emphasized by the recently conducted meta-analysis of Atieh et al. [30] . Therefore, further studies are needed to elucidate the impact of the collagenous matrix on the soft tissue keratinization of the covered root.
In the present investigation, we assessed also the two procedures in relation to post-operative pain. The SF-MPQ was used, which has been proven to be a valid and reliable instrument with good discriminative capacity for the evaluation of acute and chronic pains [13] . When focusing on a single dimension of pain intensity, our results demonstrated higher mean scores at the first post-operative day in the control group both at visual analogue scale for pain (VAS) and PPI indices (43 ± 25.49 vs. 22.50 ± 12.01 and 2.00 ± 0.41 vs. 1.25 ± 0.50, respectively). As expected, at the 2-week follow-up visit, the pain intensity scores were significantly reduced for both groups but interestingly, the CMX recipients scored slightly higher. The fact that the participants in the control group initially reported higher discomfort levels may be explained by the introduction of a second surgical site that increases postoperative morbidity. However, the higher values at the 2-week visit of the test group can be only attributed to the limited sample size of our study, considering that the course of healing was complication-free for all subjects. On the contrary, in the study by Aroca and coworkers [17] where multiple recessions were treated, the patients expressed significantly higher discomfort for the CTG recipients at 2 weeks based on their VAS analysis. However, the studies cannot be directly compared Fig. 3 Clinical pictures of one representative case from the xenogeneic collagen matrix (CMX) group and one from the connective tissue graft (CTG) group at different time points. BL, baseline; Sx1, surgical treatment graft placement; Sx2, surgical treatment visit after suturing; D14, day 14; 2M, 2 months; 6M, 6 months because the treatment of multiple recessions increases the extent of donor site wound hence the overall morbidity for the control subjects.
To our knowledge, our study was the first to use the SF-MPQ and explore the sensory and affective dimensions of pain after root coverage procedures. It was clear that the control group scored greater in the sensory qualities of the experienced post-operative discomfort at day 1 and the values were practically diminished at day 14, even though the CMX patients scored marginally higher then. The overall trends confirmed the fluctuation of the pain intensity measures. As relates to the impact of the perceived pain experience, it was interesting to note that both groups expressed low scores postsurgically albeit the CTG group measured higher at day 1. Quality-of-life analysis was not performed as part of the protocol, and as such, we cannot draw any conclusions regarding the well-being of the participants even though both procedures were well tolerated.
The reported investigation was designed to identify primarily the early vascular responses after root coverage surgeries using two types of materials and applying a laser Doppler methodology. The instrument had been previously validated and used in other forms of periodontal surgery [9, 12] , but this study provided for the first time standardized pilot data both for the subepithelial connective tissue graft and a commercially available collagenous matrix. It may be proven convenient in monitoring the clinical course of healing of other products, predicting possible deviations or complications and assessing the maturity of the surgical wound. However, we did not attempt to perform such a correlation in our study due to the limited number of subjects participating.
Moreover, the level of discomfort that patients experienced was studied in different dimensions. As patient-centered outcomes are of emerging significance [33] , studies should include as much information as possible when evaluating different techniques. In that respect, the use of the SF-MPQ was useful and in future studies, it should be supplemented by other quality-of-life instruments.
Irrespective of the aforementioned merits of this study, the results should be interpreted with caution. This was a preliminary experiment with a limited sample size; hence, only descriptive statistics were presented. A split-mouth design was not feasible; therefore, the effect of individual healing variability could not be accounted for, although this was a randomized intervention. The LDF instrument has been proven to be a reliable clinical tool; however, it is techniquesensitive and can only provide indirect evidence of the revascularization process as its recordings are based on the blood flow within the measurement tissue volume. Obviously, other imaging modalities or histological markers would have offered a more accurate representation of the revascularization events but these methods are difficult to apply in a human study as opposed to pre-clinical models.
Conclusions
Within the limits of the study, the vascular flow alterations during the early healing of CTG and CMX after root coverage procedures followed a similar pattern overall. The CMX was associated with a second period of increased blood flow, which may reflect its remodeling properties. A trend for better clinical performance in terms of root coverage and keratinized tissue gain was noted for the CTG, but the initial patient morbidity was less for CMX.
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